Advertisement
News
Advertisement

Optovue and Carl Zeiss Meditec Have Reached Settlement in Their Current Patent Infringement Disputes

Thu, 01/12/2012 - 5:05am
FREMONT, Calif. & DUBLIN, Calif.--(BUSINESS WIRE)--Optovue Inc. and Carl Zeiss Meditec Inc. announced today that they have signed a settlement agreement resolving two pending Federal District Court patent infringement cases. Under the terms of the agreement, the companies dismissed all currently pending litigation and entered into a cross-license agreement of certain issued and to be issued patents owned or controlled by each party. The specific terms of the settlement are confidential.

About Optovue® (www.optovue.com)

Optovue Inc. is a privately-held ophthalmic device company dedicated to working with eye care professionals and clinical researchers to lead the commercialization of new imaging modalities that improve diagnosis and therapy of ocular disease. Optovue has achieved widespread market success through a combination of unique data analysis design, a reputation for excellent customer service, and rapid innovation of its technology in response to physician feedback. The company is headquartered in Fremont, CA, with operations in Carlsbad, CA and European operations in Germany.

About Carl Zeiss Meditec (www.meditec.zeiss.com)

Carl Zeiss Meditec AG (ISIN: DE0005313704), which is listed on TecDAX of the German stock exchange, is one of the world´s leading medical technology suppliers. The company supplies innovative technologies and application-oriented solutions designed to help doctors improve the quality of life of their patients. It provides complete packages of solutions for the diagnosis and treatment of eye diseases - including implants and consumable materials. The company creates innovative visualisation solutions in the field of microsurgery.

The head office of Carl Zeiss Meditec is in Jena, Germany. The company has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the USA, Japan, Spain and France. Sixty-five percent of Carl Zeiss Meditec shares are held by Carl Zeiss AG. Carl Zeiss offers innovative solutions for the future-oriented markets Medical and Research Solutions, Industrial Solutions, Eye Care and Lifestyle Products. Carl Zeiss AG, Oberkochen, is wholly owned by the Carl-Zeiss Foundation.

Posted by Sean Fenske, Editor-in-Chief, MDT

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading